We have previously shown that CCL2, the ligand for CCR2 is highly expressed by brain endothelial cells from MS patients [30] and several other studies have indicated that the CCL2/CCR2 axis is crucial for the entry of monocytes to the site of inflammation [40]. The gene discussed is CCL2; the disease is myeloid sarcoma.